Peripheral nerve field stimulation and spinal cord stimulation
    52.
    发明授权
    Peripheral nerve field stimulation and spinal cord stimulation 有权
    外周神经刺激和脊髓刺激

    公开(公告)号:US09393416B2

    公开(公告)日:2016-07-19

    申请号:US14144307

    申请日:2013-12-30

    Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.

    Abstract translation: 描述了外周神经区域刺激(PNFS)与一种或多种其他疗法的结合。 与PNFS组合递送的另一疗法可以是例如不同类型的神经刺激,例如脊髓刺激(SCS)或药物。 PNFS和其他治疗可以根据时间表以交替方式同时递送,和/或选择性地,例如响应于从患者或临床医生接收到的请求。 包括PNFS的联合治疗可能能够更全面地解决复杂或多焦点疼痛,而不仅仅是通过传送PNFS或其他疗法来实现。 此外,PNFS与一种或多种其它疗法的组合可以降低神经调节可能损害所感知的有效性PNFS或其他疗法的可能性。

    DEVICES, SYSTEMS AND METHODS TO REDUCE COUPLING OF A SHIELD AND A CONDUCTOR WITHIN AN IMPLANTABLE MEDICAL LEAD
    54.
    发明申请
    DEVICES, SYSTEMS AND METHODS TO REDUCE COUPLING OF A SHIELD AND A CONDUCTOR WITHIN AN IMPLANTABLE MEDICAL LEAD 有权
    用于减少医疗领域内的屏蔽和导体耦合的装置,系统和方法

    公开(公告)号:US20150170792A1

    公开(公告)日:2015-06-18

    申请号:US14568547

    申请日:2014-12-12

    CPC classification number: A61N1/05 A61N1/086

    Abstract: Conductors within an implantable medical lead that carry stimulation signal signals are at least partially embedded within a lead body of the medical lead over at least a portion of the length of the conductors while being surrounded by a radio frequency (RF) shield. A space between the shield and the conductors is filled by the presence of the lead body material such that body fluids that infiltrate the lead over time cannot pool in the space between the shield and the conductors. The dielectric properties of the lead body are retained and the capacitive coupling between the shield and the conductors continues to be inhibited such that current induced on the shield is inhibited from being channeled onto the conductors. Heating at the electrodes of the medical lead is prevented from becoming excessive.

    Abstract translation: 携带刺激信号信号的可植入医疗引线内的导体至少部分地被埋在导体长度的至少一部分上,同时被射频屏蔽围绕。 屏蔽体和导体之间的空间被铅体材料的存在所填充,使得随着时间渗透导线的体液不能在屏蔽体和导体之间的空间中积聚。 保持引线体的介电性能,并且屏蔽体与导体之间的电容耦合继续被抑制,使得在屏蔽上感应的电流不被引导到导体上。 防止医疗用引线的电极的加热过度。

    MEDICAL LEADS AND TECHNIQUES FOR MANUFACTURING THE SAME
    55.
    发明申请
    MEDICAL LEADS AND TECHNIQUES FOR MANUFACTURING THE SAME 审中-公开
    医疗领域和制造技术的技术

    公开(公告)号:US20140343644A1

    公开(公告)日:2014-11-20

    申请号:US14206650

    申请日:2014-03-12

    CPC classification number: A61N1/05 A61N1/375

    Abstract: In some examples, the disclosure relates to a medical device comprising a lead including an electrically conductive lead wire; and an electrode electrically coupled to the lead wire, the electrode including a substrate and a coating on an outer surface of the substrate, wherein the lead wire is formed of a composition comprising titanium or titanium alloys, wherein the substrate is formed of a composition comprising one or more of titanium, tantalum, niobium, and alloys thereof, wherein the coating comprises at least one of Pt, TiN, IrOx, and poly(dioctyl-bithiophene) (PDOT). In some examples, the lead wire may be coupled to the lead wire via a weld, such as, e.g., a laser weld.

    Abstract translation: 在一些实例中,本公开涉及一种医疗装置,其包括:导线,其包括导电引线; 以及电连接到所述引线的电极,所述电极包括衬底和所述衬底的外表面上的涂层,其中所述引线由包含钛或钛合金的组合物形成,其中所述衬底由组合物形成,所述组合物包含 一种或多种钛,钽,铌及其合金,其中涂层包括Pt,TiN,IrOx和聚(二辛基 - 二噻吩)(PDOT)中的至少一种。 在一些示例中,引线可以通过焊接(例如激光焊接)耦合到引线。

    IMPLANTATION TECHNIQUES FOR ELECTRIC FIELD THERAPY

    公开(公告)号:US20230330426A1

    公开(公告)日:2023-10-19

    申请号:US18300899

    申请日:2023-04-14

    CPC classification number: A61N1/40 A61N1/0526 A61N1/3787

    Abstract: Devices, systems, and techniques are disclosed for delivering electric field therapy to tissue of a subject. In one example, a technique includes removing a tumor from tissue to create a resection cavity, implanting a plurality of leads into the tissue adjacent to the resection cavity, and affixing the plurality of leads at least one of the tissue or bone. The example technique also includes tunneling proximal ends of the leads to an implantation pocket and coupling the proximal ends of the leads to an implantable medical device configured to be placed within the implantation pocket, wherein the implantable medical is configured to deliver electric field therapy via the plurality of implantable leads disposed adjacent to the resection cavity.

    Shielded implantable medical lead with guarded termination

    公开(公告)号:US11013916B2

    公开(公告)日:2021-05-25

    申请号:US16133520

    申请日:2018-09-17

    Abstract: Implantable medical leads include a shield that is guarded at a termination by having a first portion and a second portion of the shield, where the first portion is between a termination of the shield at the second portion and an inner insulation layer that surrounds the filars. The first portion may reduce the coupling of RF energy from the termination of the shield at the second portion to the filars. The first and second portions may be part of a continuous shield, where the first and second portions are separated by an inversion of the shield. The first and second portions may instead be separate pieces. The first portion may be noninverted and reside between the termination at the second portion and the inner layers, or the first portion may be inverted to create first and second sub-portions. The shield termination at the second portion is between the first and second sub-portions.

Patent Agency Ranking